Olivier Cussenot
#151,972
Most Influential Person Now
Researcher
Olivier Cussenot's AcademicInfluence.com Rankings
Olivier Cussenotbiology Degrees
Biology
#11419
World Rank
#14812
Historical Rank
Cell Biology
#574
World Rank
#587
Historical Rank
Genetics
#1232
World Rank
#1333
Historical Rank
Molecular Biology
#1753
World Rank
#1782
Historical Rank

Download Badge
Biology
Olivier Cussenot's Degrees
- PhD Biomedical Sciences Université Paris Cité
Why Is Olivier Cussenot Influential?
(Suggest an Edit or Addition)Olivier Cussenot's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 (2007) (1156)
- REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. (2016) (1110)
- Multiple loci identified in a genome-wide association study of prostate cancer (2008) (970)
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2018) (509)
- A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci (2010) (423)
- Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. (1998) (353)
- Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. (2001) (263)
- Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3 (2011) (246)
- Identification of a new prostate cancer susceptibility locus on chromosome 8q24 (2009) (245)
- VEGF overexpression in clinically localized prostate tumors and neuropilin‐1 overexpression in metastatic forms (2000) (197)
- Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways (2001) (196)
- A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma. (2015) (194)
- HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG) (2012) (186)
- Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. (2008) (170)
- Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (163)
- Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis. (2011) (157)
- Mid‐term evaluation of the transobturator male sling for post‐prostatectomy incontinence: focus on prognostic factors (2011) (157)
- Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. (2011) (156)
- Molecular Detection of Localized Prostate Cancer Using Quantitative Methylation-Specific PCR on Urinary Cells Obtained Following Prostate Massage (2007) (156)
- Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. (1997) (153)
- Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite (2015) (151)
- Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. (2013) (149)
- PTEN/MMAC1/TEP1 involvement in primary prostate cancers (1998) (149)
- First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography‐guided biopsies for the diagnosis of localised prostate cancer (2015) (147)
- Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. (1991) (145)
- The AdVance transobturator male sling for postprostatectomy incontinence: clinical results of a prospective evaluation after a minimum follow-up of 6 months. (2009) (142)
- Quantification of expression of netrins, slits and their receptors in human prostate tumors (2003) (141)
- Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. (2011) (141)
- European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel. (2021) (136)
- Genome-wide association study identifies multiple loci associated with bladder cancer risk. (2014) (136)
- Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. (2015) (133)
- Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. (2006) (129)
- FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours. (2009) (125)
- Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases (2010) (123)
- Vitamin D receptor polymorphisms as markers in prostate cancer (1999) (121)
- Functional expression of sv40 in normal human prostatic epithelial and fibroblastic cells - differentiation pattern of nontumorigenic cell-lines. (1995) (111)
- Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old (2015) (110)
- Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. (2007) (109)
- Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility (2009) (107)
- htert expression correlates with MYC over‐expression in human prostate cancer (2000) (101)
- Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma. (1996) (101)
- Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens. (2007) (100)
- Recommandations en onco-urologie 2013 du CCAFU : Cancer de la prostate (2013) (99)
- A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. (2012) (97)
- Co-ordinated changes in expression of cell adhesion molecules in prostate cancer. (1997) (97)
- Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma (2009) (94)
- Down‐regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate (2002) (93)
- Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma. (2005) (92)
- Tubulocystic carcinoma of the kidney: a new entity among renal tumors (2007) (91)
- The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC). (2013) (90)
- Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram (2012) (90)
- Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study. (2013) (89)
- Two Susceptibility Loci Identified for Prostate Cancer Aggressiveness (2015) (88)
- Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. (2014) (88)
- Variation in KLK genes, prostate-specific antigen and risk of prostate cancer (2008) (88)
- Genetic alterations in localized prostate cancer: Identification of a common region of deletion on chromosome arm 18q (1994) (87)
- Genome-wide association study identifies multiple risk loci for renal cell carcinoma (2017) (86)
- Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer (2013) (83)
- Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants (2018) (83)
- Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA (2004) (80)
- Midterm prospective evaluation of TVT-Secur reveals high failure rate. (2010) (80)
- Promoter hypermethylation in circulating blood cells identifies prostate cancer progression (2008) (80)
- Methylated genes as potential biomarkers in prostate cancer (2010) (78)
- Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study (2013) (78)
- A widespread population study of actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia across Europe and beyond official clinical guidelines. (2010) (76)
- Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. (2006) (73)
- Does the surgical technique for management of the distal ureter influence the outcome after nephroureterectomy? (2011) (73)
- Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors (1998) (73)
- Early‐onset hereditary prostate cancer is not associated with specific clinical and biological features (2000) (72)
- Characterization of long non‐coding RNA transcriptome in clear‐cell renal cell carcinoma by next‐generation deep sequencing (2015) (71)
- Microsurgical creation and follow-up of arteriovenous fistulae for chronic haemodialysis in children (1990) (70)
- Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer. (1995) (68)
- 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy. (2013) (68)
- Laser induced autofluorescence diagnosis of bladder tumors: dependence on the excitation wavelength. (1996) (67)
- A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi‐institutional database analysis: proposal of patient‐specific risk identification tool (2012) (66)
- Gene expression profiling in clinically localized prostate cancer: a four-gene expression model predicts clinical behavior. (2003) (66)
- Immunocytochemical comparison of cultured normal epithelial prostatic cells with prostatic tissue sections. (1994) (65)
- Postoperative nomogram to predict cancer‐specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis (2014) (64)
- Molecular and histological markers in urothelial carcinomas of the upper urinary tract (2008) (63)
- Profiling and classification tree applied to renal epithelial tumours (2007) (63)
- Prevention of prostate cancer by androgens: experimental paradox or clinical reality. (2004) (62)
- Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer (2016) (62)
- Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial. (2011) (61)
- Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine (2012) (61)
- Accuracy of Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies to Diagnose Clinically Significant Prostate Cancer in Enlarged Compared to Smaller Prostates. (2015) (60)
- PCAP is the major known prostate cancer predisposing locus in families from south and west Europe (2001) (58)
- The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy (2013) (57)
- Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival (2014) (56)
- Targeted screening for prostate cancer in high risk families: early onset is a significant risk factor for disease in first degree relatives. (2002) (55)
- Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors. (2007) (55)
- Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels (2011) (55)
- A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis (2008) (55)
- Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract (2009) (55)
- UPREGULATION OF ENDOTHELIN 1 AND ITS PRECURSOR BY IL-1β, TNF-α, and TGF-β IN THE PC3 HUMAN PROSTATE CANCER CELL LINE (1999) (55)
- PGE2 and LTB4 tissue levels in benign and cancerous prostates. (2008) (55)
- Microsatellite instability in urothelial carcinoma of the upper urinary tract. (2003) (53)
- Androgens are not a direct requirement for the proliferation of human prostatic epithelium in vitro (1997) (52)
- Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives (2000) (52)
- Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma (2017) (52)
- Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. (2011) (51)
- The influence of obesity-related factors in the etiology of renal cell carcinoma—A mendelian randomization study (2019) (51)
- Soluble Isoforms of Vascular Endothelial Growth Factor Are Predictors of Response to Sunitinib in Metastatic Renal Cell Carcinomas (2010) (51)
- S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors (2004) (50)
- Argon laser induced autofluorescence may distinguish between normal and tumor human urothelial cells: a microspectrofluorimetric study. (1996) (49)
- Variations in arterial blood supply and the risk of hemorrhage during percutaneous treatment of lesions of the pelviureteral junction obstruction: report of a case of testicular artery arising from an inferior polar renal artery (2005) (49)
- Clinical practice guidelines for BRCA1 and BRCA2 genetic testing. (2021) (48)
- Recurrent cytogenetic alterations of prostate carcinoma and amplification of c‐myc or epidermal growth factor receptor in subclones of immortalized pnt1 human prostate epithelial cell line (1995) (48)
- Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome. (2005) (47)
- Telomerase activity as a potential marker in preneoplastic bladder lesions (2000) (47)
- Heterogeneity in genetic susceptibility to prostate cancer. (2001) (47)
- In vivo model mimicking natural history of dog prostate cancer using DPC‐1, a new canine prostate carcinoma cell line (2001) (47)
- [French ccAFU guidelines - Update 2018-2020: Prostate cancer]. (2018) (47)
- Oncogene amplifications in early‐stage human prostate carcinomas (1994) (47)
- Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single‐centre experience (2009) (46)
- Genome-wide interaction study of smoking and bladder cancer risk. (2014) (46)
- Non‐invasive molecular detection of bladder cancer recurrence (2002) (46)
- Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases (2015) (46)
- FGF7/KGF triggers cell transformation and invasion on immortalised human prostatic epithelial PNT1A cells (1999) (45)
- Segregation Analysis of Prostate Cancer in France: Evidence for Autosomal Dominant Inheritance and Residual Brother‐brother Dependence (2003) (45)
- Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: A systematic review (2018) (45)
- Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy (2015) (44)
- Assessment of microsatellite instability in urine in the detection of transitional‐cell carcinoma of the bladder (1998) (44)
- Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy (2015) (44)
- Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene (2004) (43)
- Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion (2003) (43)
- [French ccAFU guidelines - Update 2018-2020: Prostate cancer]. (2018) (42)
- [CCAFU french national guidelines 2016-2018 on prostate cancer]. (2016) (41)
- Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract (2012) (41)
- Expression of estrogen related proteins in hormone refractory prostate cancer: association with tumor progression. (2010) (40)
- Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy (2013) (39)
- BCAR1 expression in prostate cancer: Association with 16q23 LOH status, tumor progression and EGFR/KAI1 staining (2007) (39)
- Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancer. (1999) (38)
- Effect of Genetic Variability within 8q24 on Aggressiveness Patterns at Diagnosis and Familial Status of Prostate Cancer (2008) (38)
- Is there a contemporary role for percutaneous needle biopsy in the era of small renal masses? (2012) (38)
- Assessment of microsatellite instability in urine in the detection of transitional-cell carcinoma of the bladder. (1999) (38)
- Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. (2011) (37)
- Hereditary Prostate Cancer and Other Genetic Predispositions to Prostate Cancer (1998) (37)
- Quantitative RT‐PCR analysis of PSA and prostate‐specific membrane antigen mRNA to detect circulating tumor cells improves recurrence‐free survival nomogram prediction after radical prostatectomy (2012) (36)
- Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma. (2017) (35)
- Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations (2018) (35)
- Genetic susceptibility to prostate cancer (2005) (35)
- Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa) (2008) (35)
- Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens (2001) (35)
- Polygenic hazard score is associated with prostate cancer in multi-ethnic populations (2019) (35)
- Phenol Sulfotransferase SULT1A1*2 Allele and Enhanced Risk of Upper Urinary Tract Urothelial Cell Carcinoma (2007) (35)
- Microsatellite instability and transitional cell carcinoma of the upper urinary tract (2005) (35)
- Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma (2014) (35)
- An experimental model of bulbar urethral stricture in rabbits using endoscopic radiofrequency coagulation. (1999) (35)
- Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer (2020) (34)
- Association between estrogen and androgen receptor genes and prostate cancer risk. (2009) (34)
- Night work and prostate cancer risk: results from the EPICAP Study (2018) (34)
- Impact of prostate cancer screening on health-related quality of life in at-risk families. (2002) (34)
- Subcutaneous urinary diversions for palliative treatment of pelvic malignancies. (1995) (34)
- Association study of polymorphisms in the human estrogen receptor alpha gene and prostate cancer risk. (2003) (34)
- Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. (2016) (33)
- The Role of Laser‐Induced Autofluorescence Spectroscopy in Bladder Tumor Detection: Dependence on the Excitation Wavelength (1998) (33)
- Low circulating free and bioavailable testosterone levels as predictors of high-grade tumors in patients undergoing radical prostatectomy for localized prostate cancer. (2015) (33)
- Large-scale fine mapping of the HNF1B locus and prostate cancer risk. (2011) (33)
- Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21 (2016) (32)
- Cancer de la prostate. Épidémiologie. Facteurs de risques. Anatomopathologie (2004) (32)
- Identification of endothelin receptors in normal and hyperplasic human prostate tissues (1996) (31)
- Expression and mutational analysis of the MADR2/smad2 gene in human prostate cancer (1999) (31)
- [French ccAFU guidelines - update 2020-2022: prostate cancer]. (2020) (31)
- Upregulation of endothelin 1 and its precursor by IL-1beta, TNF-alpha, and TGF-beta in the PC3 human prostate cancer cell line. (1999) (31)
- Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate (2018) (31)
- Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive disease (2018) (31)
- Worry and attitude of men in at‐risk families for prostate cancer about genetic susceptibility and genetic testing (2002) (31)
- Familial prostate cancer cases before and after radical prostatectomy do not show any aggressiveness compared with sporadic cases. (2003) (30)
- Genetic variability in 8q24 confers susceptibility to urothelial carcinoma of the upper urinary tract and is linked with patterns of disease aggressiveness at diagnosis. (2012) (30)
- Constitutive expression of FGF2/bFGF in non‐tumorigenic human prostatic epithelial cells results in the acquisition of a partial neoplastic phenotype (1997) (30)
- Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract. (2012) (29)
- Multiparametric Magnetic Resonance Imaging Predicts Postoperative Pathology but Misses Aggressive Prostate Cancers as Assessed by Cell Cycle Progression Score. (2015) (29)
- Pharmacological and molecular evidence for the expression of the two steroid 5α‐reductase isozymes in normal and hyperplastic human prostatic cells in culture (1997) (29)
- 68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact (2020) (28)
- Differential expression of the semaphorin 3A pathway in prostatic cancer (2009) (28)
- HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin (2013) (28)
- CHC1‐L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer (2002) (28)
- Current role of image‐guided robotic radiosurgery (Cyberknife®) for prostate cancer treatment (2013) (27)
- Anatomical bases of percutaneous surgery for calculi in horseshoe kidney (2005) (27)
- Persistently elevated prostate-specific antigen at six weeks after radical prostatectomy helps in early identification of patients who are likely to recur (2012) (27)
- Ultraviolet laser-induced autofluorescence distinction between malignant and normal urothelial cells and tissues. (1996) (27)
- IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3): differential effect on PC-3 and normal prostate cell growth. (1993) (27)
- Adherence to an annual PSA screening program over 3 years for brothers and sons of men with prostate cancer. (2004) (27)
- Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease (2014) (27)
- Impact of constitutional genetic variation in androgen/oestrogen-regulating genes on age-related changes in human prostate. (2002) (26)
- Differential expression of 37 selected genes in hormone‐refractory prostate cancer using quantitative taqman real‐time RT‐PCR (2005) (26)
- Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal Ureter. (2016) (26)
- Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract. (2008) (26)
- A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry. (2020) (26)
- Detection of bladder urothelial carcinoma using in vivo noncontact, ultraviolet excited autofluorescence measurements converted into simple color coded images: a feasibility study. (2013) (25)
- Metastin (KISS-1) and metastin-coupled receptor (GPR54) expression in transitional cell carcinoma of the bladder. (2007) (25)
- The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study. (2015) (25)
- Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer (2005) (25)
- Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer. (2008) (25)
- Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry Men. (2019) (25)
- A comprehensive review of genomic landscape, biomarkers and treatment sequencing in castration-resistant prostate cancer. (2016) (25)
- Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types (2015) (24)
- A microdissection approach to detect molecular markers during progression of prostate cancer. (1995) (24)
- Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy (2010) (24)
- Differential chromosome allelic imbalance in the progression of human prostate cancer. (1996) (24)
- Refining the Prostate Cancer Genetic Association within the JAZF1 Gene on Chromosome 7p15.2 (2010) (24)
- African‐specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer (2020) (23)
- Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG) (2012) (23)
- Serum sex steroids measured in middle-aged European and African-Caribbean men by gas chromatography-mass spectrometry. (2011) (23)
- Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers (2015) (22)
- Laparoscopic fibrin glue ureteral anastomosis: experimental study in the porcine model. (1996) (22)
- Allelic losses in localized prostate cancer: association with prognostic factors. (2003) (22)
- Outcome after radical prostatectomy in young men with or without a family history of prostate cancer. (2006) (22)
- No evidence of linkage to HPC20 on chromosome 20q13 in hereditary prostate cancer (2001) (22)
- [Genetics and urology]. (2000) (21)
- Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019? (2019) (21)
- Prostate cancer local staging using biparametric MRI: assessment and comparison with multiparametric MRI. (2020) (21)
- Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours (2013) (21)
- Thérapie de sauvetage par implantation d’un sphincter artificiel urinaire après échec de bandelette Advance™ pour incontinence urinaire après prostatectomie : une expérience monocentrique ☆ (2012) (21)
- The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. (2014) (21)
- Diagnostic, staging, and grading of urothelial carcinomas from urine: performance of BCA-1, a mini-array comparative genomic hybridisation-based test. (2011) (21)
- Molecular analysis of the FHIT gene in human prostate cancer (1998) (21)
- Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone. (2015) (21)
- Tumour-associated trypsin inhibitor and renal cell carcinoma. (1995) (20)
- Caractérisation immunohistochimique des principaux types histologiques de tumeurs rénales épithéliales étudiées par tissue-arrays sur une série de 310 cas (2004) (20)
- Expression in bladder transitional cell carcinoma by real‐time quantitative reverse transcription polymerase chain reaction array of 65 genes at the tumor suppressor locus 9q34.1‐2: Identification of 5 candidates tumor suppressor genes (2004) (20)
- Oncologic outcome after radical prostatectomy in men with PSA values above 20 ng/ml: a monocentric experience (2009) (20)
- Differential Expression of Genes Related to Androgen and Estrogen Metabolism in Hereditary versus Sporadic Prostate Cancer (2008) (20)
- TVT SECUR single-incision sling after 5 years of follow-up: the promises made and the promises broken. (2012) (19)
- DNA microarrays in clinical practice: past, present, and future (2003) (19)
- Hereditary‐like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin‐based chemotherapy after radical nephroureterectomy than do sporadic tumours (2014) (19)
- Infrequent allelic imbalance at the major susceptibility HPC1 locus in sporadic prostate tumours (1997) (19)
- Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study (2021) (19)
- Facteurs de risque génétiques pour le cancer de la prostate (2004) (19)
- [Immunohistochemical characterisation of the main histologic subtypes of epithelial renal tumours on tissue-microarrays. Study of 310 cases]. (2004) (19)
- Sex specific associations in genome wide association analysis of renal cell carcinoma (2019) (19)
- Comparison of semi-automated and manual methods to measure the volume of prostate cancer on magnetic resonance imaging. (2017) (18)
- Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression. (2014) (18)
- Malnourishment in bladder cancer and the role of immunonutrition at the time of cystectomy: an overview for urologists (2014) (18)
- [Prostate cancer. Treatment]. (2004) (18)
- Relationship between non-suspicious MRI and insignificant prostate cancer: results from a monocentric study (2016) (18)
- Evolution of the landscape of surgical management of prostate cancer in France: the case of radical prostatectomy. (2012) (18)
- Percutaneous extra-anatomic nephrovesical diversion: preliminary report. (1993) (18)
- Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy (2018) (18)
- Cross‐cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy (2009) (17)
- Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures. (2012) (17)
- Inappropriate treatment of prostate cancer caused by heterophilic antibody interference (2009) (17)
- BCAR1 expression improves prediction of biochemical reccurence after radical prostatectomy (2012) (17)
- Influence of pathological factors on oncological outcomes after robot-assisted radical prostatectomy for localized prostate cancer: Results of a prospective study. (2015) (16)
- [Impact of the COVID-19 pandemic on surgical activity within academic urological departments in Paris]. (2020) (16)
- Regulation of prostate growth (2001) (16)
- International cancer seminars: a focus on kidney cancer. (2016) (16)
- Two‐photon optical imaging, spectral and fluorescence lifetime analysis to discriminate urothelial carcinoma grades (2018) (16)
- Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : cancer de la prostate (2020) (16)
- A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus (2017) (16)
- Assessment of Xpert Bladder Cancer Monitor test performance for the detection of recurrence during non-muscle invasive bladder cancer follow-up (2021) (16)
- TEP/TDM et récidive biologique d’adénocarcinome prostatique : apport du 68Ga-PSMA-11 lorsque la 18F-fluorocholine n’est pas contributive (2017) (16)
- Prostate cancer genetics. (2005) (16)
- A systematic review of the tools available for predicting survival and managing patients with urothelial carcinomas of the bladder and of the upper tract in a curative setting (2013) (16)
- CGA gene (Coding for the α subunit of glycoprotein hormones) overexpression in ERα-positive prostate tumors (2002) (15)
- Prospective, multidimensional evaluation of sexual disorders in men after laser photovaporization of the prostate. (2013) (15)
- Common colorectal cancer risk alleles contribute to the multiple colorectal adenoma phenotype, but do not influence colonic polyposis in FAP (2014) (15)
- Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry (2012) (15)
- Thermal radiofrequency induced porcine ureteral stricture: a convenient endourologic model. (1999) (15)
- Impact of adoption of a decision algorithm including PCA3 for repeat biopsy on the costs for prostate cancer diagnosis in France (2013) (15)
- Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer. (2020) (15)
- Accuracy of the routine detection of mutation in mismatch repair genes in patients with susceptibility to hereditary upper urinary tract transitional cell carcinoma (2005) (15)
- Percentage of free serum prostate-specific antigen: a new tool in the early diagnosis of prostatic cancer. (1996) (14)
- Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe (French West Indies) (2014) (14)
- Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG (2012) (14)
- Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy (2016) (14)
- Different subtypes of carcinoma in situ of the bladder do not have a different prognosis (2013) (14)
- The BRCA2 gene is not relevant to sporadic prostate tumours (1996) (14)
- HOXB13 protein expression in metastatic lesions is a promising marker for prostate origin (2016) (14)
- Impact de la pandémie de COVID-19 sur l’activité chirurgicale au sein des services d’urologie de l’Assistance Publique – Hôpitaux de Paris (2020) (14)
- A New Prostatic Stent for the Treatment of Benign Prostatic Hyperplasia in High–Risk Patients (2000) (13)
- [Cystectomy with preservation of the prostate in the treatment of bladder tumours: anatomical basis, surgical techniques, indications and results]. (2003) (13)
- Outcomes of non-self-expandable metal prostheses in strictured human ureter: suggestions for future developments. (1993) (13)
- Human prostatic cells in culture: Different testosterone metabolic profile in epithelial cells and fibroblasts from normal or hyperplastic prostates (1996) (13)
- Noninvasive detection of genetic instability in cells from prostatic secretion as a marker of prostate cancer. (2001) (13)
- Analysis of bladder cancer subtypes in neurogenic bladder tumors. (2018) (13)
- [Prostate cancer. Epidemiology. Risk factors. Pathology]. (2004) (13)
- Molecular profiling of benign prostatic hyperplasia using a large scale real-time reverse transcriptase-polymerase chain reaction approach. (2004) (13)
- Circadian genes and risk of prostate cancer: Findings from the EPICAP study (2019) (13)
- Screening, diagnosis and monitoring of sarcopenia: When to use which tool? (2022) (12)
- Current perspectives of sentinel lymph node dissection at the time of radical surgery for prostate cancer. (2016) (12)
- [Salvage therapy with artificial urinary sphincter after Advance™ male sling failure for post-prostatectomy incontinence: a first clinical experience]. (2012) (12)
- A candidate gene approach within the susceptibility region PCaP on 1q42.2-43 excludes deleterious mutations of the PCTA-1 gene to be responsible for hereditary prostate cancer. (2002) (12)
- Association between androgen receptor gene CAG trinucleotide repeat length and testicular histology in older men. (2006) (12)
- Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy (2014) (12)
- Genetic susceptibility to urinary incontinence: implication of polymorphisms of androgen and oestrogen pathways (2011) (12)
- Charlson score as a single pertinent criterion to select candidates for active surveillance among patients with small renal masses (2014) (12)
- A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models. (2020) (12)
- MP67-05 FIRST ROUND OF TRANS-RECTAL TARGETED BIOPSIES WITH MAGNETIC RESONANCE IMAGING/ULTRASOUND-FUSION IMAGES VERSUS CONVENTIONAL ULTRASOUND-GUIDED BIOPSIES FOR THE DIAGNOSIS OF LOCALISED PROSTATE CANCER. (2014) (12)
- A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry (2022) (12)
- Etude PROGENE, projet français d'analyse génétique du cancer de la prostate familial : recrutement et analyse (1996) (12)
- Circadian genes polymorphisms, night work and prostate cancer risk: Findings from the EPICAP study (2020) (11)
- CGA gene (coding for the alpha subunit of glycoprotein hormones) overexpression in ER alpha-positive prostate tumors. (2002) (11)
- Facteurs de croissance et tumeurs de la prostate (1997) (11)
- Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2019) (11)
- Effect of erythropoietin on bone marrow uptake of 18F-fluorocholine in prostate cancer: comparison with 18F-fluoride uptake. (2013) (11)
- Anatomic basis of laparoscopic surgery in the male pelvis (2005) (11)
- Forkhead box protein P3 (Foxp3) expression serves as an early chronic inflammation marker of squamous cell differentiation and aggressive pathology of urothelial carcinomas in neurological patients (2015) (11)
- Marital status and prostate cancer incidence: a pooled analysis of 12 case–control studies from the PRACTICAL consortium (2021) (11)
- Aurora-A/STK-15 Is Differentially Expressed in the Micropapillary Variant of Bladder Cancer (2009) (11)
- [Xanthogranulomatous pyelonephritis. Value of magnetic resonance imaging]. (1989) (11)
- A report of unusual crossed fused renal ectopia and minimal invasive management of calculi (2007) (11)
- [Genetic aspects in cancers of the prostate]. (1996) (11)
- Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer (2021) (11)
- Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway (2017) (11)
- From active surveillance to the concept of secondary prevention. (2011) (11)
- Adenovirus-mediated gene transfer in dog prostate: a preclinical study of a relevant model system for gene therapy of human prostatic cancer (1999) (11)
- The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor (2020) (11)
- HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG) (2012) (11)
- Séquelles fonctionnelles de la prise en charge du cancer de prostate localisé (2010) (11)
- Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer (2019) (11)
- Dépistage du cancer de la prostate : étude de 600 cas (1990) (10)
- [Growth factors and prostatic tumors]. (1997) (10)
- A four-antibody immunohistochemical panel can distinguish clinico-pathological clusters of urothelial carcinoma and reveals high concordance between primary tumor and lymph node metastases (2020) (10)
- Secondary chemoprevention of localized prostate cancer by short-term androgen deprivation to select indolent tumors suitable for active surveillance: a prospective pilot phase II study (2014) (10)
- [Hemostasis technics in partial nephrectomy]. (1996) (10)
- Clinical characteristics and pathologic findings in patients eligible for active surveillance who underwent radical prostatectomy. (2012) (10)
- Evaluation of optimal stent size after antegrade endopyelotomy: an experimental study in the porcine model. (1997) (10)
- Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinoma. (2014) (10)
- [Genetic analysis of familial prostatic cancer: localization of a gene predisposing to prostatic cancer (PCaP) on chromosome 1q 42.2-43]. (1999) (10)
- [Leiomyoma of the urinary excretory tract]. (1989) (10)
- Clinical significance of intratumoral CD8+ regulatory T cells in prostate carcinoma. (2010) (10)
- [Epidemiology of familial prostatic cancer: 4-year assessment of French studies]. (1999) (10)
- Impact of sodium 18F-fluoride PET/CT, 18F-fluorocholine PET/CT and whole-body diffusion-weighted MRI on the management of patients with prostate cancer suspicious for metastasis: a prospective multicentre study (2018) (10)
- Epithelial phenotypes in the developing human prostate. (2006) (9)
- Prostate-sparing cystectomy for bladder cancer: a step toward a dead-end. (2010) (9)
- The integrin signalling adaptor p130CAS is also a key player in prostate cancer (2011) (9)
- Tumeur urothéliale primitive du haut appareil urinaire et seconde localisation ultérieure intravésicale (2009) (9)
- No evidence for fibroblast growth factor receptor 3 (FGFR‐3) R248C/S249C mutations in human prostate cancer (2000) (9)
- Immediate Nephroureterectomy or After Attempting Conservative Treatment, on Elective Indications, for Upper Urinary Tract Urothelial Carcinoma: Comparison of the Pathology Reports on a Retrospective Monocentric Study. (2015) (9)
- Résultats carcinologiques et fonctionnels de la prostatectomie totale dans les cancers de la prostate T3 (2009) (9)
- Endourological treatment of lumbar and iliac ureteral stones. A comparative study of 49 cases. (1994) (9)
- gsSKAT: Rapid gene set analysis and multiple testing correction for rare‐variant association studies using weighted linear kernels (2017) (9)
- Urology surgical activity and COVID‐19: risk assessment at the epidemic peak: a Parisian multicentre experience (2020) (9)
- [Culturing of normal and tumor cells of the human prostate]. (1989) (8)
- Pathological findings and oncological control afforded by radical prostatectomy in men with high-risk prostate cancer: a single-centre study (2011) (8)
- [Primary upper urinary tract tumors and subsequent location in the bladder]. (2009) (8)
- Limiting radiation exposure during prostatic arteries embolization: influence of patient characteristics, anatomical conditions, and technical factors (2021) (8)
- Impact de l'obésité sur le PSA lors du dépistage du cancer de la prostate (2007) (8)
- Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer (2005) (8)
- Utilité clinique de la tomographie par émission de positons dans le cancer de la prostate (2007) (8)
- [The value of MRI in ruptures of the corpus cavernosum]. (1993) (8)
- Impact of Genotyping on Outcome of Prostatic Biopsies: A Multicenter Prospective Study (2011) (8)
- Oncologic control obtained after radical prostatectomy in men with a pathological Gleason score ≥ 8: a single-center experience. (2011) (8)
- Low penetrance genetic susceptibility to kidney cancer (2006) (8)
- Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma (2013) (8)
- Pathologic Reassessment of Prostate Cancer Surgical Specimens Before Molecular Retrospective Studies (2010) (8)
- Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center study. (2015) (8)
- [PET/CT and biochemical recurrence of prostate adenocarcinoma: Added value of 68Ga-PSMA-11 when 18F-fluorocholine is non-contributive]. (2017) (7)
- Gene transfer to urethral strictures in rabbits: a preliminary report (2000) (7)
- [Urinary and sexual disorders following localised prostate cancer management]. (2010) (7)
- Full analysis of the prostatic urethra at the time of radical cystoprostatectomy for bladder cancer: impact on final disease stage (2009) (7)
- Distinct androgen 5 alpha-reduction pathways in cultured fibroblasts and immortalized epithelial cells from normal human adult prostate. (1994) (7)
- Endoscopic Surveillance of Self-Expandable Metal Prostheses in Recurrent Urethral Strictures (1992) (7)
- Ureteral gene transfer to porcine induced strictures using endourologic delivery of an adenoviral vector. (1999) (7)
- Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24 (2021) (7)
- [Clinical usefulness of positron emission tomography in prostate cancer]. (2007) (7)
- Olfactory detection of prostate cancer by dogs (2012) (7)
- Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families (2012) (7)
- Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France (2020) (7)
- Étiologie et prise en charge de la dysfonction érectile chez l’insuffisant rénal chronique (2009) (7)
- Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case‐Control Sequencing Studies (2016) (6)
- Application of a Novel Score Test for Genetic Association Incorporating Gene-Gene Interaction Suggests Functionality for Prostate Cancer Susceptibility Regions (2011) (6)
- Restaging the Biochemical Recurrence of Prostate Cancer with [68Ga]Ga-PSMA-11 PET/CT: Diagnostic Performance and Impact on Patient Disease Management (2021) (6)
- Postoperative assessment of nosocomial transmission of COVID-19 after robotic surgical procedures during the pandemic (2020) (6)
- Functional magnetic resonance imaging and molecular pathology at the crossroad of the management of early prostate cancer (2015) (6)
- [Familial forms of cancer of the urogenital tract: clinical and genetic features]. (1996) (6)
- Dilatation congénitale de la voie biliaire (1987) (6)
- Paternité tardive : aspects spermatiques et génétiques (2006) (6)
- Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score (2021) (6)
- The Genetic Complexity of Prostate Cancer (2020) (6)
- Transition zone and anterior stromal prostate cancers: Evaluation of discriminant location criteria using multiparametric fusion-guided biopsy. (2018) (6)
- In vivo retroviral mediated gene transfer into bladder urothelium results in preferential transduction of tumoral cells. (2005) (6)
- Genetic susceptibility to prostate cancer. (2005) (6)
- Le point sur la prédisposition génétique pour le cancer de la prostate (2015) (6)
- High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy. (2005) (6)
- Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population. (2016) (6)
- Évaluation prospective du traitement de l’incontinence urinaire post-prostatectomie par injections intrasphinctériennes de cellules musculaires autologues (2011) (6)
- Bayesian predictive model to assess BRCA2 mutational status according to clinical history: Early onset, metastatic phenotype or family history of breast/ovary cancer (2021) (6)
- [Prospective evaluation of intrasphincteric injections of autologous muscular cells in patients with stress urinary incontinence following radical prostatectomy]. (2011) (6)
- Double ureter and congenital diverticulum of the ureter (2005) (6)
- Facteurs de croissance prostatiques et hypertrophie bénigne de la pr ostate Etat des connaissances actuelles et perspectives (1992) (5)
- Common Δ2 and Δ8 RB1 variants in human breast and prostate tissues (1999) (5)
- [Sexually transmitted diseases in men]. (1996) (5)
- Typology of intravesical prostatic protrusions, or so-called median lobes, in middle-aged and older men (2018) (5)
- 12p12‐13 deletion in prostate tumors and quantitative expression of CDKN1B and ETV6 candidate genes (2001) (5)
- [Impact of obesity on PSA in prostate cancer screening]. (2007) (5)
- [Role of endoscopy in the management of upper urinary tract tumors]. (2006) (5)
- Cancer de l’urètre féminin, à propos de trois cas et revue de la littérature (2008) (5)
- Prévalence et sévérité de la dysfonction érectile dans une population d'insuffisants coronariens : étude monocentrique (2008) (5)
- Epithelial Phenotypes in the Developing Human Prostate (2007) (5)
- Stratégies de diagnostic précoce et de prévention du cancer de la prostate (2010) (5)
- 576 Prediction of cancer-specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: Development of an optimized post-operative nomogram using decision curve analysis (2013) (5)
- [Pharmaco and diet based prostate cancer prevention]. (2013) (5)
- [Update on genetic predisposition to prostate cancer]. (2015) (4)
- Pharmaco-prévention et nutri-prévention des cancers de la prostate (2013) (4)
- [Prostatic growth factors and benign hypertrophy of the prostate. Current knowledge and perspectives]. (1992) (4)
- Carcinomes urothéliaux de la voie excrétrice supérieure (2005) (4)
- [Influence of plasmatic testosterone during natural history of prostate cancer: a review]. (2013) (4)
- [Prostate cancer: Diagnosis and staging]. (2004) (4)
- Differential chromosome allelic imbalance in the progression of human prostate cancer (1996) (4)
- [Erectile dysfunction and renal chronic insufficiency: etiology and management]. (2009) (4)
- Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes (2019) (4)
- [The treatment of metastasized kidney cancer. Current data and perspectives]. (1993) (4)
- Cancer de la prostate. Traitement (2004) (4)
- 292 Salvage therapy with artificial urinary sphincter after advance male sling failure for post-prostatectomy incontinence: A first clinical experience (2012) (4)
- Prise en charge du cancer de la prostate : analyse rétrospective de 808 hommes biopsiés en France (2013) (4)
- Loss of Heterozygosity at Chromosome 16 q in Prostate Adenocarcinoma : Identification of Three Independent Regions 1 (1997) (4)
- [Microsurgical creation of arteriovenous fistulas for chronic hemodialysis in children weighing less than 10 kg]. (1986) (4)
- Bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis: are they the same tumors? (2022) (4)
- [Hereditary forms of kidney cancer and genetic screening]. (2003) (4)
- Exploration and endoscopic treatment of unilateral primary haematuria: is non-specific diffuse pyelitis a real entity? (1994) (4)
- The SAFE Pilot Trial—SAlvage Focal Irreversible Electroporation—For Recurrent Localized Prostate Cancer: Rationale and Study Protocol (2022) (3)
- [Late paternity: spermatogenetic aspects]. (2006) (3)
- Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (3)
- Different Pigmentation Risk Loci for High-Risk Monosomy 3 and Low-Risk Disomy 3 Uveal Melanomas (2021) (3)
- [Oncologic and functional outcomes after radical prostatectomy in T3 prostate cancer]. (2009) (3)
- Adaptation and validation of the memorial anxiety scale for prostate cancer (MAX-PC) in a sample of French men (2019) (3)
- New experimental model of ureteropelvic junction obstruction allowing easy access for percutaneous surgery. (1997) (3)
- Relevance of PSA-nanotest on capillary blood in organised mass screening of prostate cancer (2002) (3)
- Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2019) (3)
- [The role of the laser in urology]. (1995) (3)
- Oncological outcomes of radical nephroureterectomy versus kidney-sparing surgery for elective treatment of clinically organ-confined upper tract urothelial carcinoma of the distal ureter. (2015) (3)
- Implantation intestinale de sphincter artificiels (1992) (3)
- Interprétation clinique d'une élévation du taux des PSA sanguins (2002) (3)
- Effet du traitement par pegfilgrastim sur la fixation de la fluorocholine (18F) par la moelle osseuse (2012) (3)
- Analyse morphométrique semi quantitative de l’histologie testiculaire au cours du vieillissement (2003) (3)
- 426 Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer (2012) (3)
- [Strategies for early diagnosis and prevention of prostate cancer]. (2010) (3)
- Genetic impact on prostate anatomical variability during ageing: role of CYP17, SRD5A2 and androgen receptor genes polymorphisms (2007) (3)
- Transurethral resection of bladder and radical cystectomy: Concordance of histology. Are we good enough? (2020) (3)
- Strecker stent as ureteral stent : experimental study (1992) (3)
- Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology Review. (2020) (3)
- Causes et facteurs prédictifs d’une hospitalisation postopératoire prolongée après urétéroscopie souple : expérience d’un centre hospitalo-universitaire (2020) (3)
- Incidence of bladder cancer in neuro-urological patients in France: a nationwide study (2022) (3)
- RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate (2018) (3)
- Common delta2 and delta8 RB1 variants in human breast and prostate tissues. (1999) (3)
- Genetic variability in 13q33 and 9q34 is linked to aggressiveness patterns and a higher risk of progression of non‐muscle‐invasive bladder cancer at the time of diagnosis (2020) (2)
- Imagerie de diffusion comme marqueur non invasif de l’agressivité du cancer de prostate : comparaison aux marqueurs biologiques, histologiques, immuno-histochimiques et moléculaires (2015) (2)
- Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-Institutional, Prospective Study (UROCCR Study 82) (2022) (2)
- [The PROGENE study, the French project of genetic analysis of familial prostatic cancer: recruitment and analysis]. (1996) (2)
- Relevance of the prostate‐specific antigen (PSA) nanotest compared to the classical PSA test in the organized mass screening of prostate cancer (2007) (2)
- DNA microarrays in clinical practice: present or future? (2002) (2)
- A study of the immunohistochemical profile of bladder cancer in neuro-urological patients by the French Association of Urology (2022) (2)
- [Genetic alterations in localized cancers of the prostate: identification of a common region of deletion on the chromosome 18q]. (1995) (2)
- Comparison of oncologic outcomes after radical prostatectomy in men diagnosed with prostate cancer with PSA levels below and above 4 ng/mL (2014) (2)
- [Carcinoma of Bellini's tubules]. (1995) (2)
- 996 EVOLUTION OF RADICAL PROSTATECTOMY PRACTICE IN FRANCE OVER A 10-YEAR PERIOD (2011) (2)
- Nouveaux paradigmes et enjeux dans la prise en charge des cancers de la prostate (2017) (2)
- Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (2)
- The surgical approach can be determined from the pathological specimen obtained after open or robot-assisted laparoscopic radical prostatectomy (2014) (2)
- PSA levels in unaffected first degree relatives of prostate cancer patients are higher than in men without family history of the disease (2002) (2)
- Facteur pronostiques du cancer de la prostate. Revue de la littérature et perspectives d'avenir (1994) (2)
- Quantitative proteomic determination of diethylstilbestrol action on prostate cancer. (2013) (2)
- Mise en évidence de la déformation toulousaine du crâne au Moyen Age (1989) (2)
- 316 Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy (2015) (2)
- Influence de la testostérone plasmatique au cours de l’histoire naturelle du cancer de la prostate : analyse de la littérature (2013) (2)
- What risk of prostate cancer led urologist to recommend prostate biopsies? (2015) (2)
- Stroma-epithelium interactions in prostate (1994) (2)
- Biologie moléculaire de la prostate normale et pathologique (2011) (2)
- 618 INFLUENCE OF OBESITY ON PSA LEVELS ON A SCREENED POPULATION (2007) (2)
- Post-mortem detection of HIV, HTLV, hepatitis C viral infections to reduce the risk of contamination during anatomical cadaver dissections (1999) (2)
- [Intestinal implantation of an artificial sphincter]. (1992) (2)
- Involvement of polymorphisms in androgen/oestrogen regulating genes on latent and clinical prostate cancers (2003) (2)
- Corrigendum to "French ccAFU guidelines-update 2020-2022: Prostate cancer" [Prog. Urol 30 (12 S) (2020), pp S136-S251]. (2021) (2)
- Propriétés fonctionnelles d'une nouvelle lignée de cellules endothéliales humaines immortalisées (1995) (2)
- BCAR1 EXPRESSION IN PROSTATE CANCER (2006) (2)
- Genetic susceptibility to prostate cancer : Abstract (2004) (1)
- [Correlation of genetic and cytogenetic alterations in pathological aggressiveness urothelial carcinoma of the bladder: Performance of BCA-1, a mini-array comparative genomic hybridisation-based test]. (2017) (1)
- Etude biométrique et radiologique de trois crânes «toulousains» du bas moyen âge (1990) (1)
- Évaluation précoce des troubles postopératoires après photovaporisation de la prostate Greenlight™ grâce à un questionnaire dédié (2016) (1)
- La génétique au coeur du débat ethique (2000) (1)
- Pathological reporting of cystectomy lymph nodes: a retrospective analysis of experience in Paris (2021) (1)
- [Evaluation of postoperative symptoms after Greenlight™ photovaporization of the prostate through a dedicated questionnaire]. (2016) (1)
- Analyse génétique du cancer de la pr ostate familial : localisation d'un gène prédisposant au cancer de la prostate (PCaP) sur le chromosome 1q 42.2-43 (1999) (1)
- [Laparoscopic treatment of vesico-ureteral reflux in the pig. Preliminary report]. (1994) (1)
- Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants (2018) (1)
- [Central venous stenoses after using a Hickman catheter in hemodialysis in children. Apropos of 4 cases]. (1989) (1)
- 580 IS SCREEN-DETECTED PROSTATE CANCER IN HIGH RISK FAMILIES ELIGIBLE FOR ACTIVE SURVEILLANCE? (2010) (1)
- Influence du vieillessement sur la spermatogenèse: étude histologique et cytogénétique moléculaire au niveau testiculaire chez 46 sujets âgés de 29 à 102 ans (2004) (1)
- COMPARISON OF PROSTATE CANCER GENE EXPRESSION BEFORE AND AFTER HORMONAL RELAPSE (2009) (1)
- Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study. (2022) (1)
- [Renal and urinary tract disease national research program]. (2007) (1)
- [Infertility and testicular seminoma]. (2007) (1)
- Étude française sur le dépistage du cancer de la prostate dans les familles à risque : résultats à 8 ans dans le groupe 40–49 ans (2016) (1)
- Region 2 of 8 q 24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe ( French West Indies ) (1)
- PD-L1 (SP142) testing is concordant between Benchmark Ultra and Bond-III stainers (2021) (1)
- 500 MOLECULAR DIAGNOSIS OF LOCALIZED PROSTATE CANCER BY QUANTITATIVE METHYLATION-SPECIFIC PCR GENE PATTERNS IN URINE CELLS OBTAINED BY PROSTATE MASSAGE (2007) (1)
- 837 PROTEOMICS AND GENOMICS INVESTIGATIONS OF DIETHYLSTILBESTROL ACTION ON A PROSTATE CANCER CELL LINE 22RV1 (2011) (1)
- [Transplantation of a horse-shoe kidney. Report of a case and review of the literature]. (1992) (1)
- [Genetics and germinal tumors of the testis]. (2003) (1)
- Additional SNPs improve the performance of a polygenic hazard score for prostate cancer (2020) (1)
- En cas de première série de biopsies de prostate, les biopsies prostatiques ciblées par voie transréctale avec fusion écho/IRM ont un meilleur rendement que les biopsies standard pour la détection de cancer significatif dans les prostates > 40 mL (2014) (1)
- Infertilité et séminome testiculaire (2007) (1)
- Quel niveau de risque incite l’urologue à réaliser des biopsies de la prostate ? Analyse rétrospective et multicentrique française (2013) (1)
- 1631 EVOLUTION OF RADICAL PROSTATECTOMY PRACTICE IN FRANCE OVER A 10-YR PERIOD (2011) (1)
- [Prevalence and severity of erectile dysfunction in a population with coronary insufficiency: monocentric study]. (2008) (1)
- Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum. (2022) (1)
- Standardizing immunohistochemistry methodology for evaluation of PD-1 and PDL-1 expression in upper tract urothelial carcinoma. (2021) (1)
- Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, non-invasive bladder tumors in 2019? (2019) (1)
- ANAT8 Correlations radio-anatomiques du 1er compartiment des extenseurs du poignet (2005) (1)
- 332 A systematic review and meta-analysis of clinicopathologic factors linked with intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma (2015) (1)
- Programme national de recherche sur les maladies du rein et des voies urinaires (2007) (1)
- Infertilites, ambiguites sexuelles masculines & cryptorchidies (2000) (1)
- Malformations de l'appareil urinaire et dysplasies kystiques des reins (2000) (1)
- Formes familiales des cancers de la prostate (2005) (1)
- De la surveillance active à la prévention secondaire du cancer de la prostate (2012) (1)
- [Prevalence and diversity of management of prostate cancer patients classified as low risk using D'Amico group or Cancer of the Prostate Risk Assessment (CAPRA) score: A French multicenter study]. (2017) (1)
- [Not Available]. (2014) (1)
- UP-1.179: Cure of Post-Prostatectomy Incontinence by Transobturator Male Sling (2009) (1)
- [How is prostate cancer screening perceived by men 50 to 70 years of age? Analysis based on 1,774 screened individuals]. (2007) (1)
- "Vie" et mort dans le prieuré clunisien de Saint-Nicolas d'Acy : archéologie funéraire et anthropologie (1991) (1)
- Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG) (2011) (1)
- Functional characterization of 5p15.33 risk locus in uveal melanoma reveals rs452384 as a functional variant and NKX2.4 as an allele-specific interactor (2022) (1)
- Paéopathologie d'une blessure faciale par balle observée sur un crâne nord-african: Etude Qualitative des premiers signes osseux de régénération (1995) (1)
- [Functional properties of a new line of immortalized human endothelial cells]. (1995) (1)
- Men with a family history of prostate cancer: does screening create anxiety? (2002) (1)
- 19 Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma (2014) (1)
- Clinical performance of MRI & biomarkers for prostate cancer diagnosis in men at high genetic risk. (2023) (1)
- Évolution du nombre de cystectomies totales en France pour tumeur infiltrante de la vessie au cours des 10 dernières années : analyse objective des données nationales du PMSI (2014) (1)
- Néphrectomie par voie cœlioscopique transpéritonéale pour rein non fonctionnel (2011) (1)
- Étude multicentrique sur la distribution des scores d’AMICO et CAPRA au diagnostic et sur la prise en charge des patients classés à faible risque (2014) (1)
- 694 CROSS-CULTURAL VALIDATION OF A PROGNOSTIC TOOL: EXAMPLE OF THE LIMITATIONS OF THE KATTAN PREOPERATIVE NOMOGRAM AS A PREDICTOR OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY (2009) (1)
- Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54]. (2018) (1)
- 775: Immunohistochemical Characterisation of the Main Histological Types of Epithelial Renal Tumours Using Tissue Micro-Arrays : A Study of 310 Cases (2004) (1)
- Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. (2023) (1)
- Comment le dépistage du cancer de la prostate est-il perçu par les hommes de 50 à 70 ans ? Analyse à partir de 1774 individus dépistés (2007) (1)
- Voies de carcinogenèse et histoire naturelle des tumeurs de la voie excrétrice supérieure : état de l’art pour le rapport annuel de l’Association française d’urologie (2014) (0)
- [Not Available]. (2015) (0)
- Traitement conservateur des tumeurs de la voie excrétrice supérieure : devons-nous pousser les indications ? (2017) (0)
- [Not Available]. (2015) (0)
- Dépistage du cancer de la prostate dans les familles à risque. Le nombre d’apparentés atteints et l’âge précoce de diagnostic dans la famille augmentent le risque de CaP (2017) (0)
- HOXB13, un nouveau marqueur pour distinguer le carcinome de la prostate des carcinomes d’autre origine (2013) (0)
- [Not Available]. (2015) (0)
- L’automatisation du Gleason, la fin d’un dilemme ? (2013) (0)
- La caractérisation fonctionnelle du locus de susceptibilité au cancer du rein 12p11.23 implique le gène SHARP1 (2014) (0)
- Les traitements focaux : une alternative dans la prise en charge du cancer de la prostate de bas risque ? (2017) (0)
- Therapie genique principes et applications en urologie (2000) (0)
- Expression des membres de la voie Hedgehog dans les adénocarcinomes prostatiques primitifs et en hormono-échappement (2006) (0)
- Thérapie cellulaire de l’incontinence urinaire d’effort féminine par incompétence sphinctérienne par injection intrasphinctérienne de cellules musculaires autologues : résultats à 6 ans de recul (2013) (0)
- Résultat d’un traitement chirurgical de sauvetage guidé par le résultat du TEP/TDM au 68Ga-PSMA-11 pour la récidive biologique après prostatectomie radicale (2019) (0)
- Déformation crânienne dite «Toulousaine». Etude anthropologique de crânes dans le plan sagittal (1992) (0)
- [Not Available]. (2015) (0)
- Étude de la corrélation entre le taux préopératoire de testostérone et les caractéristiques anatomopathologiques des pièces de prostatectomie radicale (2013) (0)
- Développement et validation du premier nomogramme français capable de prédire la survie spécifique postopératoire après néphro-urétérectomie pour tumeur de la voie excrétrice supérieure (2012) (0)
- Apport prédictif d’une signature moléculaire à la classification pronostique CAPRA des cancers de prostate avant prostatectomie radicale (2020) (0)
- Suivi à moyen terme après implantation de mini-bandelette Ajust™ pour le traitement de l’incontinence urinaire féminine : efficacité, complications et facteurs pronostiques (2013) (0)
- IRM multiparamétrique et biopsies ciblées : intérêt pour la détection et la caractérisation des cancers prostatiques de la zone de transition (2016) (0)
- Tumeurs de vessie sur vessie neurologique en France entre 2013 et 2016 : comparaison à une population de tumeurs sur vessie non neurologique (2021) (0)
- Thérapie génique du cancer de la prostate (1999) (0)
- Évaluation du score CCP (Prolaris® test), et de l’expression du gène PTEN, comme marqueurs prédictifs de la récidive après prostatectomie radicale (2013) (0)
- Place de l’imagerie IRM, des biopsies en fusion d’image et des nouveaux marqueurs dans la stratégie diagnostique des cancers de la prostate (2017) (0)
- Influence de la taille de la prostate sur les résultats de la photovaporisation laser de prostate : étude prospective sur 192 patients (2012) (0)
- Évaluation prospective de la mutation FGFR3 dans l’ADN urinaire comme marqueur de surveillance des récidives du cancer de la vessie (2014) (0)
- Des chiens dressés pour une nouvelle méthode de dépistage des cancers (2010) (0)
- Facteurs prédictifs et pronostics du cancer du rein à composante sarcomatoïde. Résultats d’une étude UCLA et UroCCR 45 (2018) (0)
- Radiothérapie interne vectorisée par 177Lu-PSMA-617 de l’adénocarcinome prostatique métastatique résistant à la castration : à propos d’un cas et revue de la littérature (2019) (0)
- Iconographies supplémentaires de l'article : Place de l’imagerie IRM, des biopsies en fusion d’image et des nouveaux marqueurs dans la stratégie diagnostique des cancers de la prostate (2017) (0)
- Adopter un algorithme décisionnel tenant compte du score PCA3 lors de la répétition d’une biopsie prostatique pourrait conduire à de considérables économies en France (2012) (0)
- MP2-07 A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICOPATHOLOGIC FACTORS LINKED WITH INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY TO TREAT UPPER TRACT UROTHELIAL CARCINOMA (2015) (0)
- Abstract #5613: Functional analysis of the promoter of the beta-microseminoprotein gene MSMB demonstrates the importance of a single nucleotide polymorphism in prostate cancer susceptibility (2009) (0)
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2018) (0)
- Laser-Induced Auto Fluorescence of Normal and Tumor Bladder Cells and Tissues (1996) (0)
- Abstract No. 142 Impact of Virtual Injection Software on Radiation Exposure and Operative Time during Prostate Artery Embolization (2023) (0)
- Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis (2007) (0)
- 331 Multicenter external validation of a post-operative nomogram for predicting the risk of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (2015) (0)
- [Genetic determinants of anatomical variants of the prostate]. (2008) (0)
- Abstract 826: Large-scale genome-wide association study identifies multiple novel germline susceptibility variants associated with bladder cancer risk (2021) (0)
- 457: Evolution of PSA Levels in First Degree Relatives of Prostate Cancer Patients, with Baseline PSA <=1NG/ML (2004) (0)
- [The management of prostate cancer: a retrospective chart review in 808 French men undergoing biopsy]. (2013) (0)
- [Management of prostate cancer: The new challenges]. (2017) (0)
- 250 Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage during early detection of prostate cancer (2004) (0)
- Irreversible electroporation for local prostate cancer: Oncological and functional outcomes (2020) (0)
- Use of soluble isoforms of vascular endothelial growth factor to predict response to sunitinib in metastatic renal cell carcinomas. (2010) (0)
- 941 Comparative assessment of steroids serum levels in European and African-Caribbean men using gas chromatography – mass spectrometry (2012) (0)
- [The Campaign Program for Prostate Integrated Research]. (2010) (0)
- Reply to Giuseppe Lippi's Letter to the Editor re: Jean-Nicolas Cornu, Géraldine Cancel-Tassin, Valérie Ondet, et al. Olfactory Detection of Prostate Cancer by Dogs Sniffing Urine: A Step Forward in Early Diagnosis. Eur Urol 2011;59:197-201 (2011) (0)
- 527 ONCOLOGIC CONTROL AFTER RADICAL PROSTATECTOMY IN MEN WITH CLINICAL T3 PROSTATE CANCER: A SINGLE-CENTER EXPERIENCE (2009) (0)
- Clonal phylogenies inferred from bulk, single cell, and spatial transcriptomic analysis of cancer (2023) (0)
- 900 COMPARISON OF PRE- AND POSTOPERATIVE PLASMA LEVELS OF CIRCULATING PROSTATE DERIVED CELLS IN PATIENTS WITH LOCALIZED PROSTATE CANCER IMPROVES PREDICTION OF RECURRENCE AFTER RADICAL PROSTATECTOMY (2009) (0)
- Bladder Cancer FGFR 3 Mutations Indicate Better Survival in Invasive Upper Urinary Tract and Bladder Tumours (2009) (0)
- FGFR3 mutations have different effects on disease course in tumors from the bladder, ureter, and renal pelvis (2006) (0)
- Evaluation of non-muscle-invasive bladder cancer recurrence using a mRNA-based urine test (Xpert® Bladder Cancer Monitor) and cytology (2019) (0)
- 62 Age related changes in human prostate are associated with the FGFR4 ARG388 allele (2004) (0)
- 1600 MID-TERM EVALUATION AND PROGNOSTIC FACTORS OF TRANSOBTURATOR RETROURETHRAL SLING FOR POST-PROSTATECTOMY INCONTINENCE (2010) (0)
- Total pelvic exenteration surgery for loco‐regionally advanced prostate cancer, is it justifiable? (2022) (0)
- 518 EFFECT OF FAMILY HISTORY AND GENETIC POLY- MORPHISMS ON RISK AND AGGRESSIVENESS PATTERNS OF PROSTATE CANCER (2011) (0)
- Association of Rs1139971, a KAI1 polymorphism, with bone metastasis progression in prostate cancer and ganglionnary metastasis. (2013) (0)
- 1327: Gene Expression Profiles in Benign Prostatic Hyperplasia (2004) (0)
- Diagnosis of prostate cancer in one day: The benefits of cytology in tumour detection (2020) (0)
- "Virtually Perfect" for Some but Perhaps Not for All: Launching Telemedicine in the Bronx during the COVID-19 Pandemic. Letter. (2021) (0)
- 653: Targeted Screening in High Risk Families: High Detection Rate and Positive Predictive Value of Increased PSA (>4NG/ML) in 2+ and Early Onset Prostate Cancer Families (2004) (0)
- Secondary chemoprevention using short period (3 months) of LHRHa as an option for men with low-risk localized prostate cancer (LRPC) before active surveillance (AS). (2012) (0)
- Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease (2013) (0)
- Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry (2012) (0)
- MP7-05 PROGNOSTIC VALUE OF THE PT3 SUBCLASSIFICATION FOR UPPER TRACT UROTHELIAL CARCINOMAS OF THE RENAL PELVICALYCEAL SYSTEM (2016) (0)
- 830 Evidence for frequent microsatellite instability in urothelial carcinomas of the upper urinary tract (2004) (0)
- Prostate cancer screening in high risk families: higher detection in first degree relatives even in families without obvious hereditary patterns (2002) (0)
- 2238 SINGLE NUCLEOTIDE POLYMORPHISMS ARE ASSOCIATED WITH VARIATION OF PSA LEVELS IN A CONTROL POPULATION (2012) (0)
- 646P Prostate cancer metastatic profiles correlate with molecular alterations (2020) (0)
- [Genetic features of prostatic cancer]. (2003) (0)
- A method of predicting the prognosis or diagnosis or therapeutic response of disease including prostate cancer and a device for the implementation of the PROCESS. (2008) (0)
- [Urethral cancer: report of three cases and review of the literature]. (2008) (0)
- 907 Post-operative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with pT1-T3 N0/Nx upper tract urothelial carcinoma without metastasis (2014) (0)
- ASO Visual Abstract: Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-institutional, Prospective Study (UROCCR Study 82) (2022) (0)
- 389 Three-year prostate cancer screening program in high risk families: High detection associated with the number of affected relatives and early onset (2004) (0)
- Penile Prosthesis Implantation and Infection: Experience with the “No Touch” Surgical Technique (2018) (0)
- [Toward a new border]. (2011) (0)
- 866 PLACEMENT OF A TRANSOBTURATOR MALE SLING FOR POST-OPERATIVE INCONTINENCE AFTER PROSTATE SURGERY: EVALUATION AFTER A 12 MONTHS FOLLOW-UP (2009) (0)
- 402 IMPACT OF GENOTYPING ON OUTCOME OF PROSTATIC BIOPSY IN A CLINICAL SETTING (2011) (0)
- Development and validation of a cell cycle progression signature for decentralized testing of men with prostate cancer. (2022) (0)
- Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases (2015) (0)
- 645P Prediction of BRCA2 mutations in prostate cancer patients according early onset, metastatic phenotypes or family history of breast/ovary cancer (2020) (0)
- No association between a n repeat in the promoter region of the insulin-like growth factor-1 gene and sporadic prostate and breast cancer cases (1999) (0)
- 166 SERUM SEX STEROIDS MEASURED IN MIDDLE-AGED FRENCH CAUCASIAN AND AFRICAN-CARIBBEAN MEN, KNOWN TO HAVE A DIFFERENT RISK OF PROSTATE CANCER, USING GAS CHROMATOGRAPHY-MASS SPECTROMETRY (2012) (0)
- [Transitional cell carcinoma of the upper urinary tract new concepts in management]. (2005) (0)
- Comparison of cell cycle progression (CCP) score to two IHC markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy (2018) (0)
- Title: Sex Specific Associations in Genome Wide Association Analysis of Renal Cell Carcinoma (2019) (0)
- ANATOMICAL FEATURES AND DISSECTION OF THE ACCESSORY PUDENDAL ARTERIES DURING LAPAROSCOPIC RADICAL PROSTATECTOMY (2006) (0)
- [Histologic forms of benign prostatic hyperplasia: focus on fibroblastic factors]. (2006) (0)
- 1323: Age Related Changes in Human Prostate are Associated With the FGFR4 ARG388 Allele (2004) (0)
- Family history of prostate cancer and non-affected men's worry about genetic susceptibility (2002) (0)
- Low PSA level possibly associated with long term risk of prostate cancer in young men, aged 40–49: Correlation with the number of affected first degree relatives in high risk families (2003) (0)
- 10 Metabolomics profiles of prostatic secretions from patients treated by Pygeum Africanum for low urinary tract symptoms related to benign prostatic hyperplasia (2012) (0)
- Screening trends in “at-risk” families for prostate cancer (2003) (0)
- 261 Expression and diagnostic utility of P63 and alpha-methyl-coa-racemase (P504S) cocktail in ambiguous lesion of the prostate (2004) (0)
- COMPARISON OF PRE- AND POSTOPERATIVE PLASMA LEVELS OF CIRCULATING PROSTATE DERIVED CELLS IN PATIENTS WITH LOCALIZED PROSTATE CANCER IMPROVES PREDICTION OF RECURRENCE AFTER RADICAL PROSTATECTOMY (2009) (0)
- UP-1.36: Definitive assessment of early post-operative symptoms after laser photovaporization of the prostate (PVP): validation of a dedicated questionnaire (2010) (0)
- Impact of obesity in the management of kidney cancer, study URO-CCR n°87 (2022) (0)
- [Natural history and prognostic factors of prostate cancer]. (1994) (0)
- Precision medicine in oncology needs to integrate pharmacogenetic profiling. (2015) (0)
- URETHRAL GRACILOPLASTY FOR TREATMENT OF FEMALE INTRINSIC SPHINCTER DEFICIENCY: RATIONALE FOR THE TRANSVAGINAL APPROACH (1998) (0)
- Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (0)
- Urethral graciloplasty for treatment of female intrinsic sphincter deficiency: rationale for the transvaginal approach: an anatomical study. (1998) (0)
- MP7-06 MULTICENTER EXTERNAL VALIDATION OF A POST-OPERATIVE NOMOGRAM FOR PREDICTING THE RISK OF INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA (2015) (0)
- 417 GENETIC VARIABILITY WITHIN 8Q24 CONFERS ENHANCED RISK OF UROTHELIAL CELL CARCINOMA OF THE UPPER URINARY TRACT (2010) (0)
- Establishment of permanent human endothelial cells achieved by transfection with SV40 large T antigen that retain typical phenotypical and functional characteristics (2007) (0)
- 143 EFFECT OF FAMILY HISTORY AND GENETIC POLYMORPHISMS ON RISK AND AGGRESSIVENESS OF PROSTATE CANCER (2011) (0)
- 91 HIGH ACTIVITY POLYMORPHISM WITHIN DIHYDROTESTOSTERONE SYNTHESIS ENHANCES AGGRESSIVENESS OF ADVANCED PROSTATE CANCER FOR PATIENTS CARRYING THE 8Q24 PROSTATE CANCER SUSCEPTIBILITY GENOTYPES (2010) (0)
- [Active surveillance for the secondary prevention of prostate cancer]. (2012) (0)
- Original article High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy (2005) (0)
- MP35-17 COMPARISON OF CELL CYCLE PROGRESSION (CCP) SCORE TO TWO IHC MARKERS (PTEN AND KI-67) FOR PREDICTING OUTCOME IN PROSTATE CANCER AFTER RADICAL PROSTATECTOMY. (2018) (0)
- 699 TISSULAR BIOMARKERS ASSOCIATED WITH SURVIVAL AFTER PROSTATE CANCER HORMONAL RELAPSE (2009) (0)
- Can prostate biopsy be avoided in all patients with negative MRI? Results of a multicentric study (2022) (0)
- Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488]. (2023) (0)
- 308 Effect of genetic polymorphisms on susceptibility and aggressiveness of clear cell renal cell carcinoma (2012) (0)
- Evaluation of prostate cancer tissue samples quality taken by the surgeon for molecular biology during radical prostatectomy (2003) (0)
- 814 IMPORTANCE OF ALLELIC INSTABILITY OF URINARY MICROSATELLITES MARKERS FOR CONSERVATIVE MANAGEMENT OF UPPER URINARY TRACT UROTHELIAL CELL CARCINOMA (2010) (0)
- Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of heterogeneity on genomic signature scoring (2023) (0)
- PD35-06 POST-OPERATIVE NOMOGRAM TO PREDICT CANCER-SPECIFIC SURVIVAL AFTER RADICAL NEPHROURETERECTOMY IN PATIENTS WITH PT1-T3 N0/NX UPPER TRACT UROTHELIAL CARCINOMA WITHOUT METASTASIS (2014) (0)
- 2159 THE USE OF CANINES FOR PROSTATE CANCER DETECTION: TOWARDS A NON-INVASIVE ALTERNATIVE SCREENING TOOL (2010) (0)
- POD-01.06: Monocentric Study of Feasibility and Safety of Intra-Sphincter Injections of Autologous Progenitor Muscular Cells in Patients with Urinary Incontinence Due To Sphincter Failure Following Radical Prostatectomy (2009) (0)
- Chain Reaction Assays by Real-Time Quantitative Reverse Transcription-Polymerase Progesterone Receptor Expression in Human Prostate Cancer ) , and β ER and α ER Evaluation of Androgen , Estrogen ( Updated (2001) (0)
- 808 Prognostic value of the pT3 subclassification for upper tract urothelial carcinomas of the renal pelvicalyceal system (2016) (0)
- 6 Single nucleotide polymorphisms in genes regulating steroid hormones metabolism are independently associated with increased prostate volume in men with prostate cancer (2012) (0)
- 129Reconsidering familial status of prostate cancer in sporadic and in 2 cases families, after systematic PSA based screening in first degree relatives (2005) (0)
- 2036 IMPACT OF GENOTYPING ON OUTCOME OF PROSTATIC BIOPSIES ON A CLINICAL SETTING (2011) (0)
- MP-14.16: Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection (2007) (0)
- Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2019) (0)
- 669 EXPRESSION OF ESTROGEN RELATED PROTEINS IN HORMONE-REFRACTORY PROSTATE CANCER: ASSOCIATION WITH TUMOUR PROGRESSION (2010) (0)
- DESCRIPTION OF THE SURGICAL ANATOMY OF THE FASCIAS SURROUNDING THE PROSTATE DURING LAPAROSCOPIC RADICAL PROSTATECTOMY (2006) (0)
- MP60-17 PREDICTIVE CONTRIBUTION OF A MOLECULAR SIGNATURE TO THE CAPRA PROGNOSTIC CLASSIFICATION OF PROSTATE CANCERS BEFORE RADICAL PROSTATECTOMY (2021) (0)
- MP-01.13: Actual medical management of LUTS/BPH across Europe beyond official clinical guidelines: a wide population study (2010) (0)
- 752 GENETIC VARIABILITY WITHIN 8Q24 IS ASSOCIATED WITH AGGRESSIVENESS OF ADVANCED PROSTATE CANCER SUITABLE FOR HORMONOTHERAPY (2010) (0)
- 23 DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target (2006) (0)
- Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer (2016) (0)
- C-ERB-B2, AURORA-A, MIB-1 AND P53 HAVE PREDICTIVE VALUE FOR VASCULAR INVASION AND RELAPSE IN UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMAS (2008) (0)
- T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum. (2022) (0)
- PD10-10 FOXP3 EXPRESSION SERVES AS A MARKER OF SQUAMOUS CELL DIFFERENTIATION AND AGGRESSIVE PATHOLOGY OF UROTHELIAL CARCINOMAS IN NEUROGENIC PATIENTS (2015) (0)
- Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2018) (0)
- Zonal anatomy of the prostate using magnetic resonance imaging, morphometrics, and radiomic features: impact of age-related changes. (2021) (0)
- Tissue microarray analysis of the diagnostic value of p53, Ki-67, CK 5/6, Cox-2 and STAG2 expression in urothelial carcinomas of neurogenic bladder (2017) (0)
- A EIGHT‐YEAR SCREENING PROGRAM IN HIGH RISK FAMILIES. NUMBER OF AFFECTED RELATIVES AND EARLY ONSET ARE ASSOCIATED WITH A HIGH RISK DETECTION.: MP33‐04 (2017) (0)
- PO-520 Comprehensive molecular classification of localised prostate adenocarcinoma reveals a tumour subtype predictive of a non-aggressive disease (2018) (0)
- [Carcinogenic pathways and natural history of upper tract urothelial carcinomas: state-of-the-art review for the yearly scientific report of the French National Association of Urology]. (2014) (0)
- 606Five-year prostate cancer screening program in high risk families: Results in young first degrees relatives aged 40–49 (2005) (0)
- 853 PROTEOMIC INVESTIGATION OF DIETHYLSTILBESTROL ACTION ON A PROSTATE CANCER CELL LINE 22RV1 BY 2D-DIFFERENCE GEL ELECTROPHORESIS AND MASS SPECTROMETRY (2010) (0)
- MP34-01 PREVALENCE AND DIVERSITY OF MANAGEMENT OF PROSTATE CANCER PATIENTS CLASSIFIED AS LOW RISK USING D’AMICO GROUP OR CANCER OF THE PROSTATE RISK ASSESSMENT (CAPRA) SCORE: A FRENCH MULTICENTER STUDY (2018) (0)
- Irreversible Electroporation (IRE) for Prostate Cancer (2021) (0)
- 907Survey of androgen deprivation therapy habit for prostate cancer: Results of a french study conducted with 257 urologists (2005) (0)
- 550 Cancer-specific survival after nephroureterectomy for upper urinary tract urothelial carcinoma: External validation of a predictive nomogram using a French collaborative national database (2012) (0)
- Facteurs de risque génétiquesle cancer de la prostate (2004) (0)
- Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21 (2016) (0)
- [Genetic features of urothelial carcinoma of the bladder and the upper urinary tract]. (2003) (0)
- CROSS-CULTURAL VALIDATION OF A PROGNOSTIC TOOL : EXAMPLE OF THE LIMITATIONS OF THE KATTAN PREOPERATIVE NOMOGRAM AS A PREDICTOR OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY (2009) (0)
- Abstract 3863: Fine mapping and comprehensive resequencing analysis of a region of chromosome 11q13 reveals multiple independent loci associated with prostate cancer (2010) (0)
- Molecular phenotypes in DNA repair deficiency correlate with specific clinical outcomes subtypes and genetic background (2019) (0)
- Évaluation du risque de récidive des cancers de la vessie non infiltrant le muscle par le test Xpert® Bladder Cancer Monitor à partir d’arn urinaire (2018) (0)
- Correlation of genetic and cytogenetic alterations in pathological aggressiveness urothelial carcinoma of the bladder: Performance of BCA-1, a mini-array comparative genomic hybridisation-based test (2018) (0)
- VITAMIN D RECEPTOR POLYMORPHISMS AND PROSTATE CANCER RISK IN AN EUROPEAN POPULATION (1999) (0)
- Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer (2021) (0)
- Function and Aggressive Disease The 19 q 12 Bladder Cancer GWAS Signal : Association with Cyclin E Updated (2014) (0)
- [Prognostic value of PD-1/PD-L1 expression in upper tract urothelial carcinoma]. (2018) (0)
- 44 COMPARISON OF ONCOLOGIC OUTCOMES OBTAINED AFTER OPEN OR LAPAROSCOPIC NEPHROURETE-RECTOMY FOR THE TREATMENT OF UPPER URINARY TRACT UROTHELIAL CELL CARCINOMAS (UUT-UCC): A MULTI-INSTITUTIONAL STUDY (2011) (0)
- Prostate cancer screening in high risk families: Should PSA testing be performed yearly in first degree relatives with baseline PSA ≤ 1ng/ml? (2004) (0)
- 2110 PROSPECTIVE, MULTIDIMENSIONAL EVALUATION OF SEXUAL DISORDERS IN MEN AFTER LASER PHOTOVAPORIZATION OF THE PROSTATE BY GREENLIGHT HPS (2011) (0)
- 405 PROGNOSTIC RELEVANCE OF BCAR1 EXPRESSION IN PROSTATE CANCER (2011) (0)
- QUANTITATIVE AND QUALITATIVE MULTIMODAL OPTICAL ANALYSIS TO DISCRIMINATE UROTHELIAL CARCINOMA GRADES: MP54‐18 (2018) (0)
- Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations (2018) (0)
- Quantitative and qualitative multimodal optical analysis to discriminate urothelial carcinoma grades (2018) (0)
- [Detection of cancer of the prostate. A study of 600 cases]. (1990) (0)
- [Hereditary prostate cancer]. (2004) (0)
- [Comparison of biomechanical properties of the vaginal fixation in bladder neck suspensions according to the Burch technique and a percutaneous technique]. (1999) (0)
- 907 Single nucleotide polymorphisms are associated with variation of PSA levels in a control population (2012) (0)
- Diagnosis and prognosis of prostatic cancer, comprises analysis of specific cell markers, antigens and loss of chromosomal alleles, also used for optimizing treatment (2000) (0)
- 1192 PROTEOMIC INVESTIGATION OF DIETHYLSTILBESTROL ACTION ON A PROSTATE CANCER CELL LINE 22RV1 BY 2D-DIFFERENCE GEL ELECTROPHORESIS AND MASS SPECTROMETRY (2010) (0)
- Erratum to 'Prostate cancer local staging using biparametric MRI: Assessment and comparison with multiparametric MRI' [Eur. J. Radiol. 132 (2020) 109350]. (2020) (0)
- 812 GENETIC VARIABILITY WITHIN 8Q24 CONFERS ENHANCED RISK OF UROTHELIAL CELL CARCINOMA OF THE UPPER URINARY TRACT (2010) (0)
- A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus (2017) (0)
- Frequency of allelic imbalance in prostate cancer is significantly associated with clinical and biological features (2002) (0)
- [Prognostic factors in prostate cancer. Review of the literature and future perspectives]. (1994) (0)
- Association du rs1139971, polymorphisme du gène KAI1, à la progression métastatique osseuse dans le cancer de prostate mais pas à la progression métastatique ganglionnaire (2013) (0)
- DNA damage repair gene germline profiling for metastatic prostate cancer patients of different ancestries (2022) (0)
- Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2019) (0)
- 898 IS IL-16 A PREDICTIVE MARKER OF BIOLOGIC RELAPSE IN PROSTATE CANCER? (2009) (0)
- Young-onset kidney tumors: Clinico-pathological features and subset examination of their genome-wide somatic mutations. (2015) (0)
- 896 Mid-term follow-up after Ajust™ single incision sling implantation for women stress urinary incontinence: Efficacy, complications and prognostic factors (2013) (0)
- [Focal therapies: An alternative option for low-risk prostate cancer management?] (2017) (0)
- 361 A COMPARATIVE ANALYSIS OF THE BEHAVIOUR OF UROTHELIAL CARCINOMA WITH RESPECT TO ANATOMICAL LOCATION (2007) (0)
- Clinical value of the integration of Prostate Health Index (PHI) in multiparametric MRI-based diagnostic strategies to detect clinically-significant prostate cancer. Results from the French prospective multicenter PHI-1 study (2020) (0)
- [Not Available]. (2015) (0)
- 1619: Plasma Estrogens in Newly Diagnosed Patients for Prostate Cancer (2007) (0)
- [Role of prostate MRI, TRUS fusion biopsies and new markers in the diagnostic strategy of prostate cancer]. (2017) (0)
- [High-risk clinically localised prostate cancer]. (2010) (0)
- Selective cytotoxicity of a replication-selective adenovirus, dl 118, for prostatic cancer cell lines in vitro (2002) (0)
- Microsurgical creation and follow up angioaccesses for chronic hemodialysis in children weighing under 10 kg (1988) (0)
- 702 TISSULAR BIOMARKERS ASSOCIATED WITH THE TIME TO HORMONAL RELAPSE IN PROSTATE CANCER (2009) (0)
- 1 Title : Post-hoc Analysis for Detecting Individual Rare Variant Risk Associations using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing Studies Running Title : Bayesian Probit Rare Variant Analysis (2017) (0)
- PROSTATE CANCER SCREENING IN HIGH RISK FAMILIES. A EIGHT‐YEAR PROSPECTIVE PROGRAM IN YOUNG FIRST DEGREE RELATIVES AGED 40‐49.: PD07‐11 (2017) (0)
- Sex specific associations in genome wide association analysis of renal cell carcinoma (2019) (0)
- [Causes and predictive factors of prolonged length of hospital stay after flexible ureteroscopy: Experience of a large volume institution]. (2020) (0)
- 284: Molecular Diagnosis of Localized Prostate Cancer by Quantitative Methylation-Specific PCR Gene Patterns in Urine Cells Obtained by Prostate Massage (2007) (0)
- [Developing strategies for active surveillance]. (2010) (0)
- 1056 Detection of FGFR3 mutations from urine sediment DNA to predict the risk of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (2015) (0)
- Effet biologique du sérum humain recueilli avant et après une administration par voie orale de Pygeum africanum, sur diverses cultures de cellules bénignes de la prostate (2012) (0)
- 792 COMPARISON OF PROSTATE CANCER GENE EXPRESSION BEFORE AND AFTER HORMONAL RELAPSE (2009) (0)
- 624 PROTEOMICS AND GENOMICS INVESTIGATIONS OF DIETHYLSTILBESTROL ACTION ON A PROSTATE CANCER CELL LINE 22RV1 (2011) (0)
- Impact de l’obésité dans la prise en charge du cancer du rein, étude URO-CCR N°87 (2021) (0)
- Intérêt pronostique de l’expression de PD-1/PD-L1 dans les tumeurs de la voie excrétrice urinaire supérieure (2018) (0)
- [Not Available]. (2015) (0)
- Comparaison des performances diagnostiques du Prostate Health Index (PHI) et du Prostate Cancer Antigen 3 (PCA-3) pour le dépistage du cancer de la prostate (2014) (0)
- Iconographies supplémentaires de l'article : Pharmaco-prévention et nutri-prévention des cancers de la prostate (2015) (0)
- Influence de l’obésité sur le type histologique des tumeurs rénales opérées, étude URO-CCR N°69 (2021) (0)
- Le genome humain (2000) (0)
- Facteurs génétiques déterminant les variations anatomiques de la prostate (2008) (0)
- Autoévaluations de l'article : Biologie moléculaire de la prostate normale et pathologique (2011) (0)
- Une revue systématique des polymorphismes simples pour un nucléotide associés au cancer de la prostate (2012) (0)
- Résultats périopératoires et oncologiques de la néphro-urétérectomie totale par voie laparoscopique pure versus robot assistée pour le traitement des tumeurs de la voie excrétrice urinaire supérieure (2015) (0)
- [Not Available]. (2015) (0)
- Carcinome renal a cellules claires : recherche protéomique de biomarqueurs par technique iTRAQ ® (2012) (0)
- Évaluation du risque de contamination par le coronavirus après chirurgie robotique durant la pandémie COVID-19 (2020) (0)
- Facteurs histologiques associés au pronostic oncologique après prostatectomie robot-assistée (2015) (0)
- Intérêt du dosage sérique du TPA (tissue polypeptide antigen) dans les tumeurs de la vessie (1993) (0)
- Impact pronostique de l’expression de pd-1 et pd-l1 pour les tumeurs de la voie excrétrice supérieure (2022) (0)
- Néphro-urétérectomie d’emblée ou après tentative de traitement conservateur dans les tumeurs de la voie excrétrice supérieure : comparaison des résultats anatomopathologiques (2013) (0)
- Les marqueurs biologiques pronostiques du cancer de la prostate (1994) (0)
- Formes histologiques des hypertrophies bénignes de la prostate (HBP) : focus sur les facteurs fibroblastiques (2006) (0)
- Amélioration de l’efficacité de la photothérapie dynamique de prostate au wst11 par une immunothérapie ciblant le récepteur csf1r : étude préclinique (2018) (0)
- Cancers de la prostate cliniquement localisés à haut risque de progression (2010) (0)
- Génétique des tumeurs germinales du testicule (2006) (0)
- Iconographies supplémentaires de l'article : Nouveaux paradigmes et enjeux dans la prise en charge des cancers de la prostate (2017) (0)
- Iconographies supplémentaires de l'article : Biologie moléculaire de la prostate normale et pathologique (2011) (0)
- Formes familiales de cancer de la prostate: « marchesur le(s) gène(s) de prédisposition (1996) (0)
- Évaluation du risque de récidive vésicale par la recherche de la mutation FGFR3 sur l’ADN urinaire prélevé avant néphro-uréterectomie pour le traitement d’une tumeur de la voie excrétrice supérieure (2015) (0)
- Étude de la sexualité chez des patients traités par photovaporisation laser de prostate : une série prospective de 109 patients (2012) (0)
- Valeur pronostique de la sous-classification pT3 des tumeurs de la voie excrétrice urinaire supérieure localisées dans les cavités pyélocalicielles (2015) (0)
- Dépistage du cancer de la prostate: Quand et comment utiliser les PSA (2002) (0)
- Étude de l’influence de l’expression de Foxp3 (Forkhead box protein) sur la survie des patients neuro-urologiques ayant une tumeur de vessie (2015) (0)
- [Not Available]. (2014) (0)
- Author Index and Subject Index (1998) (0)
- FOXP3 est un marqueur tissulaire tumoral chez les patients neurologiques ayant une tumeur de vessie (2014) (0)
- CHAPITRE 1. Les cancers hormonodépendants (2020) (0)
- Tumeurs de la voie excrétrice supérieure : développement d’un modèle international postopératoire de prédiction de la survie après néphro-urétérectomie à l’aide de l’analyse des courbes de décision (2013) (0)
- Validation externe du nomogramme prédictif de la récidive vésicale après néphro-urétérectomie totale pour le traitement des tumeurs de la voie excrétrice urinaire supérieure (2014) (0)
- Corrélation des altérations génétiques à l’agressivité anatomo-pathologique des carcinomes urothéliaux de la vessie : performance du test BCA-1 (2017) (0)
- Urologie - Carcinomes urothéliaux de la voie excrétrice supérieure (2008) (0)
- Impact de l’âge et de la densité du PSA sur la détection du cancer de prostate chez les patients avec IRM prostatique négative (2021) (0)
- [Not Available]. (2014) (0)
- Électroporation irréversible du cancer de la prostate localisé : résultats oncologiques et fonctionnels (2020) (0)
- Revue systématique de la littérature et méta-analyse des facteurs de risque de récidive vésicale après néphro-uréterectomie totale pour le traitement d’une tumeur de la voie excrétrice urinaire supérieure (2015) (0)
- Cancer de la prostate : passé, présent et futur (1998) (0)
- Effets pharmacogénomique du Prostaphane® sur des cellules cancéreuses de prostate (2015) (0)
- Facteurs de risque génétiques le cancer (2004) (0)
- Comparaison du score de progression du cycle cellulaire (CCP) et de deux marqueurs immunohistochimiques (PTEN et KI67) pour la prédiction du cancer de la prostate après prostatectomie radicale (2017) (0)
- Vers une nouvelle frontière (2011) (0)
- Développer les stratégies de surveillance active (2010) (0)
- La performance du test urinaire Xpert® Bladder Cancer Monitor est supérieure à celle de la cytologie pour la détection des récidives des tumeurs de la vessie n’infiltrant pas le muscle (2020) (0)
- [Not Available]. (2014) (0)
- [Not Available]. (2014) (0)
- Prévalence et diversité de la prise en charge des patients atteints de cancer de la prostate classés à faible risque selon la classification de d’Amico ou le score de CAPRA : étude française multicentrique (2017) (0)
- Thérapie génique du cancer de la prostate : principes et modalité d'application : Cancer de la prostate (1998) (0)
- Rôle du polymorphisme génétique comme facteur de susceptibilité et d’agressivité du carcinome rénal à cellules claires (2012) (0)
- [Not Available]. (2015) (0)
- Culture cellulaire de l'épithélium prostatique humain normal, immortalisé et transformé : applications en cancérologie expérimentale (1994) (0)
- [Not Available]. (2014) (0)
- 1582 SINGLE NUCLEOTIDE POLYMORPHISMS IN GENES REGULATING STEROID HORMONES METABOLISM ARE INDEPENDENTLY ASSOCIATED WITH INCREASED PROSTATE VOLUME (2012) (0)
- Impact sur la composition corporelle et le style de vie du suivi personnalisé par télémédecine des patients traités pour un cancer de la prostate par association radio-hormonothérapie utilisant la leuproréline 45 mg (2018) (0)
- [Not Available]. (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Olivier Cussenot?
Olivier Cussenot is affiliated with the following schools: